Clinical Trials
4
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Analysis of Volatile Organic Compounds in the Breath of Lung Transplant Rejection Patients Using Infrared Spectroscopy
- Conditions
- Lung Transplant Rejection
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Paragonix Technologies
- Target Recruit Count
- 35
- Registration Number
- NCT06309628
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
- Conditions
- Liver Transplant RejectionLiver Transplant DisorderLiver DiseasesLiver Dysfunction
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Paragonix Technologies
- Target Recruit Count
- 1000
- Registration Number
- NCT05082077
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸Stanford University, Stanford, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
- Conditions
- COPDCystic FibrosisEmphysemaPulmonary Arterial HypertensionInterstitial Lung DiseasePulmonary Fibrosis
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Paragonix Technologies
- Target Recruit Count
- 2000
- Registration Number
- NCT04930289
- Locations
- 🇺🇸
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸Stanford Medicine, Stanford, California, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Global Utilization And Registry Database for Improved heArt preservatioN
- Conditions
- Heart DiseasesHeart FailureHeart Defects, Congenital
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- Paragonix Technologies
- Target Recruit Count
- 3000
- Registration Number
- NCT04141605
- Locations
- 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸Medstar Washington Hospital, Washington DC, District of Columbia, United States
🇺🇸University of Florida Health Shands Hospital, Gainesville, Florida, United States
News
Paragonix Secures EU MDR Approval for Five Organ Preservation Devices, Expanding European Market Access
Paragonix Technologies has received EU Medical Device Regulation approval for five organ preservation devices, confirming compliance with Europe's most stringent quality standards for medical devices.
Paragonix KidneyVault Receives FDA Clearance for Portable Kidney Perfusion
Paragonix Technologies' KidneyVault, a portable hypothermic perfusion system, has received FDA 510(k) clearance to improve donor kidney preservation during transport.
Paragonix Technologies' KidneyVault Receives FDA Clearance for Portable Kidney Perfusion
Paragonix Technologies has received FDA 510(k) clearance for its KidneyVault System, a portable hypothermic perfusion device for donor kidney preservation.
Paragonix Kidney Vault Receives FDA Approval for Organ Transport
Paragonix Technologies' Kidney Vault has received FDA approval, enhancing the preservation and transportation of kidneys for transplantation.